Aptar Pharma, a global solution provider of aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, has obtained a State Food and Drug Administration (SFDA) import license approval to deliver its preservativefree multi-dose systems to customers in China.
The license approval represents a further step in Aptar Pharma’s ongoing service development to provide large-scale production services to customers, mainly for its Ophthalmic Squeeze Dispenser (OSD) and its Advanced Preservative Free
spray pump (APF).
In China, the pharmaceutical sector remains dynamic, outpacing growth in developed countries. The import of packaging materials for pharmaceutical products requires an “Examination and approval for packaging materials and containers in direct contact with drugs” from the SFDA before being placed on the market. Now that this import license approval has been granted for the Ophthalmic Squeeze Dispenser (OSD) and Advanced Preservative-Free Systems (APF), pharmaceutical and biotechnology companies can directly import Aptar Pharma’s preservative free multi-dose systems into the Chinese market.
The OSD is manufactured in a class ISO 7 cleanroom at the Aptar Pharma state-of-the-art production facility in Eingeltingen, Germany.